Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Monogram Orthopaedics Inc ( (MGRM) ).
Monogram Technologies announced the mandatory conversion of its 8.00% Series D Convertible Cumulative Preferred Stock, following a public offering that closed on October 1, 2024. This conversion was triggered on July 7, 2025, when the company’s common stock price met the required threshold for ten consecutive trading days, and it will be effective as of July 14, 2025. This move reflects Monogram’s strategic financial management and could impact its stock liquidity and shareholder value.
The most recent analyst rating on (MGRM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Monogram Technologies Inc. (NASDAQ: MGRM) is an AI-driven robotics company focused on improving human health, particularly in orthopedic surgery. The company is developing solutions for patient-optimized orthopedic implants using 3D printing, machine vision, AI, and robotics. Their mBôs precision robotic surgical system aims to enhance knee replacement procedures, and they have obtained FDA clearance for their mBôs TKA System and mPress implants.
Average Trading Volume: 57,548
Technical Sentiment Signal: Strong Buy
For an in-depth examination of MGRM stock, go to TipRanks’ Overview page.